Insinga A - Search Results

1

Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.

Carbone R, Botrugno OA, Ronzoni S, Insinga A, Di Croce L, Pelicci PG, Minucci S. Carbone R, et al. Among authors: insinga a. Mol Cell Biol. 2006 Feb;26(4):1288-96. doi: 10.1128/MCB.26.4.1288-1296.2006. Mol Cell Biol. 2006. PMID: 16449642 Free PMC article.

2

PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors.

Minucci S, Monestiroli S, Giavara S, Ronzoni S, Marchesi F, Insinga A, Diverio D, Gasparini P, Capillo M, Colombo E, Matteucci C, Contegno F, Lo-Coco F, Scanziani E, Gobbi A, Pelicci PG. Minucci S, et al. Among authors: insinga a. Blood. 2002 Oct 15;100(8):2989-95. doi: 10.1182/blood-2001-11-0089. Blood. 2002. PMID: 12351412 Free article.

3

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.

Insinga A, Monestiroli S, Ronzoni S, Carbone R, Pearson M, Pruneri G, Viale G, Appella E, Pelicci P, Minucci S. Insinga A, et al. EMBO J. 2004 Mar 10;23(5):1144-54. doi: 10.1038/sj.emboj.7600109. Epub 2004 Feb 19. EMBO J. 2004. PMID: 14976551 Free PMC article.

4

Leukemia-associated fusion proteins. Multiple mechanisms of action to drive cell transformation.

Insinga A, Pelicci PG, Inucci S. Insinga A, et al. Cell Cycle. 2005 Jan;4(1):67-9. doi: 10.4161/cc.4.1.1400. Epub 2005 Jan 19. Cell Cycle. 2005. PMID: 15611639 Review.

5

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway.

Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, Altucci L, Nervi C, Minucci S, Pelicci PG. Insinga A, et al. Nat Med. 2005 Jan;11(1):71-6. doi: 10.1038/nm1160. Epub 2004 Dec 26. Nat Med. 2005. PMID: 15619634 Free article.

6

Mechanisms of selective anticancer action of histone deacetylase inhibitors.

Insinga A, Minucci S, Pelicci PG. Insinga A, et al. Cell Cycle. 2005 Jun;4(6):741-3. doi: 10.4161/cc.4.6.1717. Epub 2005 Jun 7. Cell Cycle. 2005. PMID: 15908787 Free article.

7

The emerging role of p53 in stem cells.

Bonizzi G, Cicalese A, Insinga A, Pelicci PG. Bonizzi G, et al. Among authors: insinga a. Trends Mol Med. 2012 Jan;18(1):6-12. doi: 10.1016/j.molmed.2011.08.002. Epub 2011 Sep 7. Trends Mol Med. 2012. PMID: 21907001 Free article.

8

DNA damage response in adult stem cells.

Insinga A, Cicalese A, Pelicci PG. Insinga A, et al. Blood Cells Mol Dis. 2014 Apr;52(4):147-51. doi: 10.1016/j.bcmd.2013.12.005. Epub 2014 Jan 28. Blood Cells Mol Dis. 2014. PMID: 24484934 Review.

9

DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.

Insinga A, Cicalese A, Faretta M, Gallo B, Albano L, Ronzoni S, Furia L, Viale A, Pelicci PG. Insinga A, et al. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3931-6. doi: 10.1073/pnas.1213394110. Epub 2013 Feb 15. Proc Natl Acad Sci U S A. 2013. PMID: 23417300 Free PMC article.

10

Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.

Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S. Cordenonsi M, et al. Among authors: insinga a. Cell. 2003 May 2;113(3):301-14. doi: 10.1016/s0092-8674(03)00308-8. Cell. 2003. PMID: 12732139 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page